Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The CACNA1C gene encodes the alpha-1C subunit of a voltage-dependent L-type calcium channel (CaV1.2). This protein is crucial for mediating calcium influx into cells upon membrane depolarization, essential for cardiac action potentials, neurotransmission, gene expression, and other physiological processes. Mutations or dysregulation are linked to cardiac arrhythmias, neurodevelopmental disorders, and psychiatric conditions.
Calcium channel blocker
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Calcium channel protein subunit alpha1C (CACNA1C).